Stay fully informed. Get the latest news from Brooklyn ImmunoTherapeutics.

January 20, 2022

Brooklyn ImmunoTherapeutics Welcomes Erin S. Enright and Heather B. Redman to Its Board of Directors

January 13, 2022

Brooklyn ImmunoTherapeutics Provides Update on Regenerative Medicine Intellectual Property Portfolio

December 17, 2021

Brooklyn ImmunoTherapeutics Added to ICE Biotechnology Index

December 14, 2021

Brooklyn ImmunoTherapeutics Named to Nasdaq Biotechnology Index

December 2, 2021

Brooklyn ImmunoTherapeutics to Present at Two Upcoming December Conferences

November 29, 2021

Brooklyn ImmunoTherapeutics Welcomes Susan McClatchey as Vice President and Head of Quality

October 14, 2021

Brooklyn ImmunoTherapeutics to Move Stock Exchange Listing to Nasdaq

September 22, 2021

Brooklyn ImmunoTherapeutics Appoints Roger Sidhu, M.D. as Chief Medical Officer

September 21, 2021

Brooklyn ImmunoTherapeutics Provides Highlights of Shareholder Update Call from September 20, 2021

September 13, 2021

Brooklyn ImmunoTherapeutics to Conduct Shareholder Update Conference Call on Monday, September 20, 2021, at 4:30 PM ET